Nevertheless, our protocol did detect monomeric forms as well as soluble oligomeric conformations of Aβ, which are pivotal to trigger Tau hyperphosphorylation, and neuronal dysfunction, leading to cognitive deficits in AD pathology (39, 86–91). The gene discussed is MAPT; the disease is Alzheimer disease.